| Product Code: ETC6560451 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Bulgaria`s import of therapeutic vaccines in 2024 saw a significant increase in concentration, with top exporters being Italy, USA, Sweden, Germany, and the UK. Despite a steep decline in growth rate from 2023 to 2024, the compound annual growth rate (CAGR) for the period 2020-24 remained impressive at 20.01%. This trend indicates a strong Market Top 5 Importing Countries and Market Competition (HHI) Analysis demand for therapeutic vaccines in Bulgaria, with key players maintaining a dominant presence in the Market Top 5 Importing Countries and Market Competition (HHI) Analysis , potentially shaping the competitive landscape for the foreseeable future.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bulgaria Therapeutic Vaccines Market Overview |
3.1 Bulgaria Country Macro Economic Indicators |
3.2 Bulgaria Therapeutic Vaccines Market Revenues & Volume, 2022 & 2032F |
3.3 Bulgaria Therapeutic Vaccines Market - Industry Life Cycle |
3.4 Bulgaria Therapeutic Vaccines Market - Porter's Five Forces |
3.5 Bulgaria Therapeutic Vaccines Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Bulgaria Therapeutic Vaccines Market Revenues & Volume Share, By Therapeutic Vaccines, 2022 & 2032F |
4 Bulgaria Therapeutic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Bulgaria, driving the demand for therapeutic vaccines. |
4.2.2 Growing awareness about preventive healthcare measures and the benefits of vaccination. |
4.2.3 Government initiatives to promote vaccination programs and improve healthcare infrastructure. |
4.3 Market Restraints |
4.3.1 Limited access to advanced healthcare facilities and vaccines in remote areas of Bulgaria. |
4.3.2 High cost associated with therapeutic vaccines, limiting affordability for some segments of the population. |
4.3.3 Regulatory challenges and stringent approval processes for introducing new vaccines in the market. |
5 Bulgaria Therapeutic Vaccines Market Trends |
6 Bulgaria Therapeutic Vaccines Market, By Types |
6.1 Bulgaria Therapeutic Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Bulgaria Therapeutic Vaccines Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Bulgaria Therapeutic Vaccines Market Revenues & Volume, By Peptide Therapeutic Vaccine, 2022 - 2032F |
6.1.4 Bulgaria Therapeutic Vaccines Market Revenues & Volume, By Cell Therapeutic Vaccine, 2022 - 2032F |
6.1.5 Bulgaria Therapeutic Vaccines Market Revenues & Volume, By Nucleic Acid Therapeutic Vaccine, 2022 - 2032F |
6.2 Bulgaria Therapeutic Vaccines Market, By Therapeutic Vaccines |
6.2.1 Overview and Analysis |
6.2.2 Bulgaria Therapeutic Vaccines Market Revenues & Volume, By Oncotherapy, 2022 - 2032F |
6.2.3 Bulgaria Therapeutic Vaccines Market Revenues & Volume, By Hepatitis B, 2022 - 2032F |
6.2.4 Bulgaria Therapeutic Vaccines Market Revenues & Volume, By Tuberculosis, 2022 - 2032F |
6.2.5 Bulgaria Therapeutic Vaccines Market Revenues & Volume, By Herpes Simplex Virus, 2022 - 2032F |
6.2.6 Bulgaria Therapeutic Vaccines Market Revenues & Volume, By Others, 2022 - 2032F |
7 Bulgaria Therapeutic Vaccines Market Import-Export Trade Statistics |
7.1 Bulgaria Therapeutic Vaccines Market Export to Major Countries |
7.2 Bulgaria Therapeutic Vaccines Market Imports from Major Countries |
8 Bulgaria Therapeutic Vaccines Market Key Performance Indicators |
8.1 Vaccination coverage rate among the target population in Bulgaria. |
8.2 Number of research and development collaborations for developing innovative therapeutic vaccines. |
8.3 Percentage of healthcare professionals trained in administering therapeutic vaccines effectively. |
9 Bulgaria Therapeutic Vaccines Market - Opportunity Assessment |
9.1 Bulgaria Therapeutic Vaccines Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Bulgaria Therapeutic Vaccines Market Opportunity Assessment, By Therapeutic Vaccines, 2022 & 2032F |
10 Bulgaria Therapeutic Vaccines Market - Competitive Landscape |
10.1 Bulgaria Therapeutic Vaccines Market Revenue Share, By Companies, 2025 |
10.2 Bulgaria Therapeutic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here